Great Lakes Retirement Inc. lowered its position in Haleon plc (NYSE:HLN – Free Report) by 9.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 20,929 shares of the company’s stock after selling 2,252 shares during the quarter. Great Lakes Retirement Inc.’s holdings in Haleon were worth $172,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also added to or reduced their stakes in HLN. Barclays PLC boosted its holdings in Haleon by 56.4% in the second quarter. Barclays PLC now owns 3,317 shares of the company’s stock valued at $28,000 after acquiring an additional 1,196 shares during the last quarter. Hollencrest Capital Management raised its stake in Haleon by 21.5% during the first quarter. Hollencrest Capital Management now owns 7,114 shares of the company’s stock worth $58,000 after buying an additional 1,258 shares during the last quarter. Farther Finance Advisors LLC lifted its holdings in Haleon by 79.3% in the second quarter. Farther Finance Advisors LLC now owns 2,986 shares of the company’s stock valued at $25,000 after buying an additional 1,321 shares during the period. Apollon Wealth Management LLC grew its holdings in Haleon by 11.0% during the 1st quarter. Apollon Wealth Management LLC now owns 13,404 shares of the company’s stock worth $109,000 after acquiring an additional 1,332 shares during the period. Finally, Financial Advocates Investment Management raised its position in shares of Haleon by 10.5% in the 3rd quarter. Financial Advocates Investment Management now owns 14,849 shares of the company’s stock worth $124,000 after acquiring an additional 1,408 shares in the last quarter. Institutional investors own 6.67% of the company’s stock.
Wall Street Analyst Weigh In
Separately, Argus reaffirmed a “buy” rating on shares of Haleon in a research note on Tuesday. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy”.
Haleon Trading Down 0.4 %
NYSE:HLN opened at $8.50 on Friday. Haleon plc has a 12 month low of $7.70 and a 12 month high of $9.05. The company has a current ratio of 1.04, a quick ratio of 0.73 and a debt-to-equity ratio of 0.53. The stock has a market capitalization of $39.22 billion, a price-to-earnings ratio of 30.34, a PEG ratio of 2.23 and a beta of 0.30. The firm has a fifty day simple moving average of $8.32 and a two-hundred day simple moving average of $8.29.
Haleon Announces Dividend
The company also recently announced a semi-annual dividend, which will be paid on Thursday, May 16th. Stockholders of record on Friday, March 15th will be paid a $0.1064 dividend. The ex-dividend date is Thursday, March 14th. This represents a dividend yield of 1.8%. Haleon’s dividend payout ratio is presently 75.00%.
Haleon Company Profile
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
See Also
- Five stocks we like better than Haleon
- Want to Profit on the Downtrend? Downtrends, Explained.
- 3 Value Stocks Too Small For Buffett’s Portfolio
- What are earnings reports?
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- Basic Materials Stocks Investing
- Disney Stock Catches 3 Upgrades In a Single Week
Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Haleon plc (NYSE:HLN – Free Report).
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.